Pavord, I., Wechsler, M., Busse, W., Domingo, C., Xia, C., Gall, R., . . . Deniz, Y. (2025). Dupilumab efficacy in patients with type 2 asthma and early FENO level reductions.
Citación estilo ChicagoPavord, ID, et al. Dupilumab Efficacy in Patients With Type 2 Asthma and Early FENO Level Reductions. 2025.
Cita MLAPavord, ID, et al. Dupilumab Efficacy in Patients With Type 2 Asthma and Early FENO Level Reductions. 2025.
Precaución: Estas citas no son 100% exactas.